Atlas Trials

Study of Abiraterone Acetate in Subjects With Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT04056754 · COMPLETED

Trial details

NCT number
NCT04056754
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Castration Resistant Prostate Cancer
Start date
2014-07-16
Primary completion
2018-03-14
Enrollment
268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.